Regulation of Macrophage Activation and Differentiation in Atherosclerosis

키워드

참고문헌 (106)

1. Tall AR, "Cholesterol, inflammation and innate immunity", Nat Rev Immunol, 15, pp.104~116 (2015)
2. Hansson GK, "The immune system in atherosclerosis", Nat Immunol, 12, pp.204~212 (2011)
3. Moore KJ, "Macrophages in atherosclerosis : a dynamic balance", Nat Rev Immunol, 13, pp.709~721 (2013)
4. Moore KJ, "Macrophages in the pathogenesis of atherosclerosis", Cell, 145, pp.341~355 (2011)
5. Herrington W, "Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease", Circ Res, 118, pp.535~546 (2016)
6. Cheng AY, "Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines", Curr Opin Cardiol, 21, pp.400~404 (2006)
7. Tabas I, "Monocyte-macrophages and T cells in atherosclerosis", Immunity, 47, pp.621~634 (2017)
8. Libby P, "Progress and challenges in translating the biology of atherosclerosis", Nature, 473, pp.317~325 (2011)
9. Gordon S, "Alternative activation of macrophages : mechanism and functions", Immunity, 32, pp.593~604 (2010)
10. Murray PJ, "Macrophage activation and polarization : nomenclature and experimental guidelines", Immunity, 41, pp.14~20 (2014)
11. Sica A, "Macrophage plasticity and polarization : in vivo veritas", J Clin Invest, 122, pp.787~795 (2012)
12. Mosser DM, "Exploring the full spectrum of macrophage activation", Nat Rev Immunol, 8, pp.958~969 (2008)
13. Glass CK, "Molecular control of activation and priming in macrophages", Nat Immunol, 17, pp.26~33 (2016)
14. Kuznetsova T, "Transcriptional and epigenetic regulation of macrophages in atherosclerosis", Nat Rev Cardiol, 17, pp.216~228 (2020)
15. Lawrence T, "Transcriptional regulation of macrophage polarization : enabling diversity with identity", Nat Rev Immunol, 11, pp.750~761 (2011)
16. Koelwyn GJ, "Regulation of macrophage immunometabolism in atherosclerosis", Nat Immunol, 19, pp.526~537 (2018)
17. Palsson-McDermott EM, "Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages", Cell Metab, 21, pp.65~80 (2015)
18. Tannahill GM, "Succinate is an inflammatory signal that induces IL-1β through HIF-1α", Nature, 496, pp.238~242 (2013)
19. Jha AK, "Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization", Immunity, 42, pp.419~430 (2015)
20. Van den Bossche J, "Mitochondrial dysfunction prevents repolarization of inflammatory macrophages", Cell Reports, 17, pp.684~696 (2016)
21. Tan Z, "Pyruvate dehydrogenase kinase 1participates in macrophage polarization via regulating glucose metabolism", J Immunol, 194, pp.6082~6089 (2015)
22. Nomura M, "Fatty acid oxidation in macrophage polarization", Nat Immunol, 17, pp.216~217 (2016)
23. Li B, "The role of chromatin during transcription", Cell, 128, pp.707~719 (2007)
24. Kittan NA, "Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes", PLoS One, 8, pp.e78045~ (2013)
25. Kaikkonen MU, "Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription", Mol Cell, 51, pp.310~325 (2013)
26. De Santa F, "Jmjd3 contributes to the control of gene expression in LPS-activated macrophages", EMBO J, 28, pp.3341~3352 (2009)
27. Kruidenier L, "A selective jumonji H3K27demethylase inhibitor modulates the proinflammatory macrophage response", Nature, 488, pp.404~408 (2012)
28. Ishii M, "Epigenetic regulation of the alternatively activated macrophage phenotype", Blood, 114, pp.3244~3254 (2009)
29. Satoh T, "The Jmjd3-Irf4 axis regulates M2macrophage polarization and host responses against helminth infection", Nat Immunol, 11, pp.936~944 (2010)
30. Mullican SE, "Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation", Genes Dev, 25, pp.2480~2488 (2011)
31. Chen X, "Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages", Proc Natl Acad Sci U S A, 109, pp.E2865~ (2012)
32. Cochain C, "Single-Cell RNA-Seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis", Circ Res, 122, pp.1661~1674 (2018)
33. Stöger JL, "Distribution of macrophage polarization markers in human atherosclerosis", Atherosclerosis, 225, pp.461~468 (2012)
34. Ginhoux F, "New insights into the multidimensional concept of macrophage ontogeny, activation and function", Nat Immunol, 17, pp.34~40 (2016)
35. Benoit M, "Macrophage polarization in bacterial infections", J Immunol, 181, pp.3733~3739 (2008)
36. Brånén L, "Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice", Arterioscler Thromb Vasc Biol, 24, pp.2137~2142 (2004)
37. Ohta H, "Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice", Atherosclerosis, 180, pp.11~17 (2005)
38. Oberoi R, "Anti-tumor necrosis factor-αtherapy increases plaque burden in a mouse model of experimental atherosclerosis", Atherosclerosis, 277, pp.80~89 (2018)
39. Seino Y, "Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions", Cytokine, 6, pp.87~91 (1994)
40. Schieffer B, "Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques : potential implications for inflammation and plaque instability", Circulation, 101, pp.1372~1378 (2000)
41. Sukovich DA, "Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice : inhibition by 17beta-estradiol", Arterioscler Thromb Vasc Biol, 18, pp.1498~1505 (1998)
42. Cardilo-Reis L, "Interleukin-13protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype", EMBO Mol Med, 4, pp.1072~1086 (2012)
43. Rahman K, "Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression", J Clin Invest, 127, pp.2904~2915 (2017)
44. Lin JD, "Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression", JCI Insight, 4, pp.e124574~ (2019)
45. Guo L, "CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis", J Clin Invest, 128, pp.1106~1124 (2018)
46. Kadl A, "Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2", Circ Res, 107, pp.737~746 (2010)
47. Stewart CR, "CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer", Nat Immunol, 11, pp.155~161 (2010)
48. Sheedy FJ, "CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation", Nat Immunol, 14, pp.812~820 (2013)
49. Miller YI, "Toll-like receptor 4-dependent and-independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages", Arterioscler Thromb Vasc Biol, 25, pp.1213~1219 (2005)
50. Duewell P, "NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals", Nature, 464, pp.1357~1361 (2010)
51. Cyster JG, "25-Hydroxycholesterols in innate and adaptive immunity", Nat Rev Immunol, 14, pp.731~743 (2014)
52. Chistiakov DA, "Mechanisms of foam cell formation in atherosclerosis", J Mol Med(Berl), 95, pp.1153~1165 (2017)
53. Williams JW, "Cytokine circuits in cardiovascular disease", Immunity, 50, pp.941~954 (2019)
54. Park YM, "CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima", J Clin Invest, 119, pp.136~145 (2009)
55. van Gils JM, "The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques", Nat Immunol, 13, pp.136~143 (2012)
56. Kim K, "Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models", Circ Res, 123, pp.1127~1142 (2018)
57. Tangirala RK, "Identification of macrophage liver X receptors as inhibitors of atherosclerosis", Proc Natl Acad Sci U S A, 99, pp.11896~11901 (2002)
58. Hamada M, "MafB promotes atherosclerosis by inhibiting foam-cell apoptosis", Nat Commun, 5, pp.3147~ (2014)
59. Hasegawa H, "The role of macrophage transcription factor MafB in atherosclerotic plaque stability", Atherosclerosis, 250, pp.133~143 (2016)
60. Li Z, "Krüppel-like factor 4 regulation of cholesterol-25-hydroxylase and liver x receptor mitigates atherosclerosis susceptibility", Circulation, 136, pp.1315~1330 (2017)
61. Gold ES, "ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation", J Exp Med, 209, pp.807~817 (2012)
62. De Nardo D, "High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3", Nat Immunol, 15, pp.152~160 (2014)
63. Bekkering S, "Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes", Arterioscler Thromb Vasc Biol, 34, pp.1731~1738 (2014)
64. Christ A, "Western diet triggers NLRP3-dependent innate immune reprogramming", Cell, 172, pp.162~175 (2018)
65. Lee SJ, "Oxidized low-density lipoprotein stimulates macrophage 18F-FDG uptake via hypoxia-inducible factor-1α activation through Nox2-dependent reactive oxygen species generation", J Nucl Med, 55, pp.1699~1705 (2014)
66. van der Valk FM, "Oxidized phospholipids on lipoprotein(a)elicit arterial wall inflammation and an inflammatory monocyte response in humans", Circulation, 134, pp.611~624 (2016)
67. Bekkering S, "Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo", Atherosclerosis, 254, pp.228~236 (2016)
68. Woollard KJ, "Monocytes in atherosclerosis : subsets and functions", Nat Rev Cardiol, 7, pp.77~86 (2010)
69. Gautier EL, "Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis", Arterioscler Thromb Vasc Biol, 29, pp.1412~1418 (2009)
70. Tacke F, "Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques", J Clin Invest, 117, pp.185~194 (2007)
71. Smith JD, "Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor(op)and apolipoprotein E", Proc Natl Acad Sci U S A, 92, pp.8264~8268 (1995)
72. Rajavashisth T, "Heterozygous osteopetrotic(op)mutation reduces atherosclerosis in LDL receptor-deficient mice", J Clin Invest, 101, pp.2702~2710 (1998)
73. Sinha SK, "Local M-CSF(macrophage colony-stimulating factor)expression regulates macrophage proliferation and apoptosis in atherosclerosis", Arterioscler Thromb Vasc Biol, 41, pp.220~233 (2021)
74. Carlin LM, "Nr4a1-dependent Ly6C(low)monocytes monitor endothelial cells and orchestrate their disposal", Cell, 153, pp.362~375 (2013)
75. Auffray C, "Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior", Science, 317, pp.666~670 (2007)
76. Hanna RN, "The transcription factor NR4A1(Nur77)controls bone marrow differentiation and the survival of Ly6C-monocytes", Nat Immunol, 12, pp.778~785 (2011)
77. Hanna RN, "NR4A1(Nur77)deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis", Circ Res, 110, pp.416~427 (2012)
78. Li P, "NR4A1 contributes to high-fat associated endothelial dysfunction by promoting CaMKII-Parkin-mitophagy pathways", Cell Stress Chaperones, 23, pp.749~761 (2018)
79. Robbins CS, "Local proliferation dominates lesional macrophage accumulation in atherosclerosis", Nat Med, 19, pp.1166~1172 (2013)
80. Schyns J, "Non-classical tissue monocytes and two functionally distinct populations of interstitial macrophages populate the mouse lung", Nat Commun, 10, pp.3964~ (2019)
81. Feig JE, "Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques", Circulation, 123, pp.989~998 (2011)
82. Feig JE, "HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells", Proc Natl Acad Sci U S A, 108, pp.7166~7171 (2011)
83. Lieu HD, "Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion", Circulation, 107, pp.1315~1321 (2003)
84. Llodrá J, "Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques", Proc Natl Acad Sci U S A, 101, pp.11779~11784 (2004)
85. Dubland JA, "So Much Cholesterol : the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation", Curr Opin Lipidol, 27, pp.155~161 (2016)
86. Cherepanova OA, "Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective", Nat Med, 22, pp.657~665 (2016)
87. Rong JX, "Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading", Proc Natl Acad Sci U S A, 100, pp.13531~13536 (2003)
88. Shankman LS, "KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis", Nat Med, 21, pp.628~637 (2015)
89. Holycross BJ, "Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation", Circ Res, 71, pp.1525~1532 (1992)
90. Barrett TB, "Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall", Proc Natl Acad Sci U S A, 85, pp.2810~2814 (1988)
91. Owens GK, "Molecular regulation of vascular smooth muscle cell differentiation in development and disease", Physiol Rev, 84, pp.767~801 (2004)
92. Williams KJ, "The response-to-retention hypothesis of early atherogenesis", Arterioscler Thromb Vasc Biol, 15, pp.551~561 (1995)
93. Ma S, "Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36", Lipids Health Dis, 10, pp.53~ (2011)
94. Costales P, "K domain CR9 of low density lipoprotein(LDL)receptor-related protein 1(LRP1)is critical for aggregated LDL-induced foam cell formation from human vascular smooth muscle cells", J Biol Chem, 290, pp.14852~14865 (2015)
95. Rivera J, "Accumulation of serum lipids by vascular smooth muscle cells involves a macropinocytosis-like uptake pathway and is associated with the downregulation of the ATP-binding cassette transporter A1", Naunyn Schmiedebergs Arch Pharmacol, 386, pp.1081~1093 (2013)
96. Allahverdian S, "Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis", Circulation, 129, pp.1551~1559 (2014)
97. Deaton RA, "Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle", Am J Physiol Heart Circ Physiol, 296, pp.H1027~ (2009)
98. Kapoor N, "Transcription factors STAT6 and KLF4implement macrophage polarization via the dual catalytic powers of MCPIP", J Immunol, 194, pp.6011~6023 (2015)
99. Vengrenyuk Y, "Cholesterol loading reprograms the microRNA-143", 145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype, 2015, pp.35, 535~546
100. Feil S, "Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis", Circ Res, 115, pp.662~667 (2014)
101. Ridker PM, "Antiinflammatory therapy with canakinumab for atherosclerotic disease", N Engl J Med, 377, pp.1119~1131 (2017)
102. Libby P, "Inducible interleukin-1 gene expression in human vascular smooth muscle cells", J Clin Invest, 78, pp.1432~1438 (1986)
103. Libby P, "Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells", Am J Pathol, 124, pp.179~185 (1986)
104. Zhuang T, "Endothelial Foxp1 suppresses atherosclerosis via modulation of Nlrp3 inflammasome activation", Circ Res, 125, pp.590~605 (2019)
105. Haneklaus M, "NLRP3 at the interface of metabolism and inflammation", Immunol Rev, 265, pp.53~62 (2015)
106. Gomez D, "Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice", Nat Med, 24, pp.1418~1429 (2018)

관련 논문AI추천